Gilles De La Tourette Syndrome; Gts
Description
Tourette syndrome is a neurobehavioral disorder manifest particularly by motor and vocal tics and associated with behavioral abnormalities. Tics are sudden, brief, intermittent, involuntary or semi-voluntary movements (motor tics) or sounds (phonic or vocal tics). They typically consist of simple, coordinated, repetitive movements, gestures, or utterances that mimic fragments of normal behavior. Motor tics may range from simple blinking, nose twitching, and head jerking to more complex throwing, hitting, or making rude gestures. Phonic tics include sniffling, throat clearing, blowing, coughing, echolalia, or coprolalia. Males are affected about 3 times more often than females, and onset usually occurs between 3 and 8 years of age. By age 18 years, more than half of affected individuals are free of tics, but they may persist into adulthood (review by Jankovic, 2001).
Genes related to Gilles De La Tourette Syndrome; Gts
- CFTR
- CAMTA1
- WDR7
- DRD3
- POLR3B
- POU1F1
- SLITRK1
- COL27A1
- PHEX
- LSAMP
- TRPC4
- NECTIN1
- LINC01122
- HDC
Clinical Features
Top most frequent phenotypes and symptoms related to Gilles De La Tourette Syndrome; Gts
- Behavioral abnormality
- Depressivity
- Pectus excavatum
- Myoclonus
- Hyperactivity
- Autism
- Anxiety
- Aggressive behavior
- Autistic behavior
- Attention deficit hyperactivity disorder
And another 27 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Gilles De La Tourette Syndrome; Gts Is also known as ts, tourette syndrome, tourette disorder.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Gilles De La Tourette Syndrome; Gts Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Ashkenazic Genetic Disease Panel.
By Baylor Miraca Genetics Laboratories (United States).
CFTR, HEXA, ELP1, ASPA
Specificity
25 %
Genes
8 % |
CFTR - 5T Variant Analysis.
By Baylor Miraca Genetics Laboratories (United States).
CFTR
Specificity
100 %
Genes
8 % |
CFTR Comprehensive - Sequence & Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
CFTR
Specificity
100 %
Genes
8 % |
CFTR Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
CFTR
Specificity
100 %
Genes
8 % |
CFTR Sequence Analysis.
By Baylor Miraca Genetics Laboratories (United States).
CFTR
Specificity
100 %
Genes
8 % |
CFTR Sequence Analysis (Familial Mutation/Variant Analysis).
By Baylor Miraca Genetics Laboratories (United States).
CFTR
Specificity
100 %
Genes
8 % |
CFTR Sequence Analysis (Prenatal Diagnosis).
By Baylor Miraca Genetics Laboratories (United States).
CFTR
Specificity
100 %
Genes
8 % |
GeneAware Complete Panel Version 2 (Female).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)
View the complete list with 139 more genes
Specificity
1 %
Genes
8 % |
You can get up to 424 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
MESH OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like WERNER SYNDROME; WRN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS CHILBLAIN LUPUS 2; CHBL2 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD